DexTech Medical AB

DexTech Medical operates in biotechnology. The company conducts research and development in the field of urological oncology, where common diseases include prostate cancer. A large part of the research is carried out in collaboration with other international players, research institutes and universities. The largest operations are found in the Nordic market. The company was founded in 2004 and is headquartered in Uppsala.

Quotes for DexTech Medical AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Anders Holmberg

Chairperson of the Board

  • Andreas Segerros

Board

  • Per-Olov Asplund
  • Peter Benson
  • Rolf Eriksson
  • Svante Wadman
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    Hearing med DexTech

    Largest Owners

    Name Capital % Votes % Date
    Svante Wadman 21,45 21,45 2025-06-26
    Anders Holmberg 8,51 8,51 2025-06-26
    Sten Nilsson 7,75 7,75 2025-06-26
    Donald Ericsson Fastigheter VI AB 6,08 6,08 2025-06-26
    Gösta Lundgren 5,96 5,96 2025-06-26
    Hans Andersson med familj 5,60 5,60 2023-02-20
    Nordnet Pensionsförsäkring 3,63 3,63 2025-06-26
    Avanza Pension 3,60 3,60 2025-06-26
    Mats Ragnarsson Holmberg 2,32 2,32 2025-06-26
    Peter Kanekrans 2,07 2,07 2025-06-26
    ** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

    Insider trading

    *Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

    Key Numbers

    *Compiled data from Millistream

    Upcoming reports

    • 2025-11-03 Delårsrapport 2026-Q1

    • 2025-11-04 Årsstämma 2025

    • 2026-02-25 Delårsrapport 2026-Q2

    • 2026-05-05 Delårsrapport 2026-Q3

    • 2026-08-31 Bokslutskommuniké 2026

    Annual reports, prospectus etc.